More on Vivus (VVUS): Q4 misses across the board as loss widened as operating expenses soared to...


More on Vivus (VVUS): Q4 misses across the board as loss widened as operating expenses soared to $58.3M in the latest period. In contrast, the company recognized just $2M in product revenue from Qsymia sales. Analysts on average expected sales of around $3M. Shares -2.8% AH.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs